Skip to main content
. 2022 Jan 26;14(3):624. doi: 10.3390/cancers14030624

Figure 2.

Figure 2

Cancer-associated ectoproteases as potential drug targets and implications in cancer therapy. Cancer is supported by a number of biologic hallmark capabilities that enable tumour development and progression. Ectoproteases participate in cancer by modulating a wide range of these processes. Drug candidates targeting ectoproteases may elicit antitumour effects (T) in a context-dependent manner.